Jazz Pharmaceuticals Price Target Announced at $337.00/Share by Goldman Sachs
Ratings actions from Benzinga
Related stories
Trump Criticises Republican Massie Over Push To Impeach US DefSec Hegseth
Defends Hegseth, Citing Recruitment Highs
L impact | NEWS | Nov 10, 2026, 01:40 AM UTC
Japan Finance Minister Katayama: Panel Broadly Welcomed Retail JGB Plan
Will Hear A Range Of Views In Reviewing JGB Products
L impact | NEWS | Nov 10, 2026, 01:26 AM UTC
PBoC Injects 190B Yuan Through Overnight Reverse Repos At 1.25%
PBoC Injects Net 8B Yuan At Open Market Operations
L impact | NEWS | Nov 10, 2026, 01:21 AM UTC
Japan FinMin Katayama: no decisions made on preferential tax treatment for retail JGBs, leaves debate to LDP
L impact | NEWS | Nov 10, 2026, 01:20 AM UTC
Japan finmin Katayama: some smaller banks concerned about funds moving to retail JGBs
L impact | NEWS | Nov 10, 2026, 01:20 AM UTC
Australia PM Albanese: all review suggests compulsory company reporting on misaligned behaviour or cyber incidents
L impact | NEWS | Nov 10, 2026, 01:07 AM UTC